Browsing by Author Kris, Mark G

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2015HER2 insertion YVMA mutant lung cancer: Long natural history and response to afatinibCooper, Wendy Anne; Lee, Adrian; Li, B T; O'Toole, Sandra; Pavlakis, Nick; Yu, Bing; Arcila, Maria E; Chaft, Janie E; Kris, Mark G; Central Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Pathology; Central Clinical School: Pathology; Northern Clinical School: Medicine; Central Clinical School: MedicineHER2 insertion YVMA mutant lung cancer: Long natural history and response to afatinib, Lung Cancer, vol.90, 3, 2015,pp 617-619
2016A prospective study of total plasma cell-free DNA as a predictive biomarker for response to systemic therapy in patients with advanced non-small-cell lung cancersLi, Bob; Azzoli, Christopher Gerard; Drilon, Alexander D.; Hsu, Meier; Johnson, Melissa; Kris, Mark G; McGinn, C.; Sima, Camelia; Sugita, H.; Central Clinical School: PathologyA prospective study of total plasma cell-free DNA as a predictive biomarker for response to systemic therapy in patients with advanced non-small-cell lung cancers, Annals of Oncology, vol.27, 1, 2016,pp 154-159
2016Serum biomarkers associated with clinical outcomes fail to predict brain metastases in patients with stage IV non-small cell lung cancersLi, Bob; Azzoli, Christopher Gerard; Daras, Mariza; DeAngelis, Lisa; Fleisher, Martin; Hsu, Meier; Johnson, Melissa; Kris, Mark G; Lou, Emil; Naidoo, Jarushka; Sima, Camelia; Yu, Helena; Zauderer, Marjorie G; Central Clinical School: PathologySerum biomarkers associated with clinical outcomes fail to predict brain metastases in patients with stage IV non-small cell lung cancers, PloS One, vol.11, 1, 2016,pp 1-12